Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05072158 · ClinicalTrials.gov registry record
Pelvic Floor Disorders Among Sexual Minoritized Women
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 18
- Enrollment target
NCT05072158: Clinical Trial study, sponsored by University of New Mexico.
NCT05072158 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05072158 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The investigators aim to perform cognitive interviews to assess how pelvic floor disorders impact sexual functioning in women who have sex with women (WSW). As a secondary objective there will be cognitive interviews to assess perceptions of sexual function questionnaires such as Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) in WSW.
Primary Outcome
We will assess the impact of pelvic floor disorders with qualitative analysis and informational interviews
Interventions
- OTHER None, this is an observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2022-06-29 |
Why NCT05072158 stopped before completion
NCT05072158 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which None, this is an observational study is the first listed.
NCT05072158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05072158 about?
NCT05072158 is a clinical study titled "Pelvic Floor Disorders Among Sexual Minoritized Women". The investigators aim to perform cognitive interviews to assess how pelvic floor disorders impact sexual functioning in women who have sex with women (WSW). As a secondary objective there will be cognitive interviews to assess perceptions of sexual function questionnaires such as Female Sexual Funct...
What is the current status of trial NCT05072158?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2021-10-14. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT05072158?
The interventions under investigation include: None, this is an observational study (OTHER).
Who is sponsoring clinical trial NCT05072158?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI